BEHANDLUNG MIT MELATONINAGONISTEN

European patent · EP2028937 · In force

Register entry

Publication number
EP2028937
Application number
EP07797634
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Maintained in amended form
Filed
May 22, 2007
Published
Mar 4, 2009
Granted
Jan 28, 2015
Protection ends at the latest
May 21, 2027
Next annual fee due
May 31, 2027
IPC classes
A61K 31/405 (2006.01)
A61P 43/00 (2006.01)
Priority
US 747847 P 22.05.2006
PCT application
PCT/US2007/069411 22.05.2007
PCT publication
WO2007/137244 29.11.2007
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 8, 2023

    Change

    Published in Swissreg on 08.06.2023

  5. Sep 23, 2020

    Address changed

    Representative
    Keller Schneider Patent- und Markenanwälte AG, Beethovenstrasse 49, 8002 Zürich → Keller Schneider Patent- und Markenanwälte AG (Bern), Eigerstrasse 2, Postfach, 3000 Bern 14

    Published in Swissreg on 23.09.2020

  6. Sep 22, 2020

    Address changed

    Representative
    Keller & Partner Patentanwälte AG, Eigerstrasse 2, Postfach, 3000 Bern 14 → Keller Schneider Patent- und Markenanwälte AG, Beethovenstrasse 49, 8002 Zürich

    Published in Swissreg on 22.09.2020

  7. Jun 27, 2018

    Change

    Published in Swissreg on 27.06.2018

  8. Apr 30, 2015

    Address changed

    Owner
    Vanda Pharmaceuticals Inc., 9605 Medical Center Drive, Suite 300, Rockville NY 20850, USA → Vanda Pharmaceuticals Inc., 2200 Pennsylvania Ave NW, Suite 300-E, Washington, DC 20037, USA

    Published in Swissreg on 30.04.2015

2 earlier entries
  1. Apr 30, 2015

    Agent entered

    Representative
    Keller & Partner Patentanwälte AG, Eigerstrasse 2, Postfach, 3000 Bern 14

    Published in Swissreg on 30.04.2015

  2. Jan 28, 2015

    Granted

    Published in Swissreg on 28.01.2015

Parties

Holder

Vanda Pharmaceuticals Inc.

2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037, US

Agent

Keller Schneider Patent- und Markenanwälte AG

Keller Schneider Patent- und Markenanwälte AG (Bern)

Eigerstrasse 2 Postfach, 3000 Bern 14

Inventor

BIRZNIEKS, Gunther

Bethesda, MD 20817, US

PHADKE, Deepak

Olathe, KS 66062, US

POLYMEROPOULOS, Mihael, H.

Potomac, MD 20854, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.